| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029353 |
| Receipt No. | R000033548 |
| Scientific Title | Open single-group comparative study on oxygen uptake during walking training Simultaneously Combined with Neuromuscular Electrical Stimulation (NMES) of Antagonists for adult male |
| Date of disclosure of the study information | 2017/09/29 |
| Last modified on | 2019/07/02 (Ver. 5) |
| Basic information | ||
| Public title | Open single-group comparative study on oxygen uptake during walking training Simultaneously Combined with Neuromuscular Electrical Stimulation (NMES) of Antagonists for adult male | |
| Acronym | Open single-group comparative study on oxygen uptake during walking training Simultaneously Combined with Neuromuscular Electrical Stimulation (NMES) of Antagonists for adult male | |
| Scientific Title | Open single-group comparative study on oxygen uptake during walking training Simultaneously Combined with Neuromuscular Electrical Stimulation (NMES) of Antagonists for adult male | |
| Scientific Title:Acronym | Open single-group comparative study on oxygen uptake during walking training Simultaneously Combined with Neuromuscular Electrical Stimulation (NMES) of Antagonists for adult male | |
| Region |
|
|
| Condition | ||
| Condition | Healthy person | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | A Hybrid Training System (HTS) that creates resistance to the motion of a voluntarily contracting agonist muscle by means of the force generated by its electrically stimulated antagonist has been developed. In collaboration with Panasonic Corporation in 2014, we developed a "hiza trainer" which is an HTS device that can be conveniently used by elderly people. Treadmill walking training with and without a hiza trainer are performed for adult male. Oxygen uptake during walking training are compared. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Expired gas is measured at resting bedding and at walking training at 4 km/h and 5.6 km/h with and without a hiza trainer. The average value of oxygen intake in each section is taken. The value in the case of wearing the hiza trainer and the value in the case of not wearing the hiza trainer are compared in each section. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | All participants are measured for height and body weight, and performed two walking training tests.
Participants are measured for gas exchange during walking training according to the following protocol. First protocol: They are rested bed for 5 minutes, and walk at 4 km/h for 5 minutes, walk at 5.6 km/h for 5 minutes. In each section, expired gas is measured. Second Protocol: They wear hiza trainers. They are rested bed for 5 minutes, and walk at 4 km/h for 5 minutes, walk at 5.6 km/h for 5 minutes. In each section, expired gas is measured. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | For those who meet all of the following criteria
1) Male over 20 years old 2) Persons who got consent on this exam |
|||
| Key exclusion criteria | Those who fall under any of the following exclusion criteria are excluded from the target
1) Impossible to use household low frequency treatment equipment 2) People who can not walk on their own will be. 3) Hospitalized person 4) For people with acute illness 5) Those with malignant tumors 6) Infectious disease people 7) Persons with severe heart, kidney and liver problems 8) Those with a body temperature of 38 degrees Celsius or higher (thermophilic term) (e.g. when there is a strong period of acute inflammatory symptoms (fatigue, chill, blood pressure fluctuation etc), weakness) 9) Anemia with clinical symptoms 10) High blood pressure and diabetes who can not control treatment 11) One with some abnormality (infection, wound etc.) in the thigh skin 12) Persons who have acute (painful) disorders such as fractures, sprains, muscles of the spine 13) Advanced peripheral circulation disorder due to diabetes etc. or peripheral nerve disorder 14) Those who feel abnormality in the body other than the above 15) Persons with limb paralysis 16) Persons wearing implantable medical electronic devices such as pacemakers 17) Persons using life-saving medical electronic equipment such as artificial heart-lung 18) Wearing a wearable medical electronic device such as an electrocardiograph 19) Venous and arterial thrombus 20) Persons who are prohibited from exercising by a doctor 21) Persons who can not walk independently 22) For people with analgesia 23) If you can not display (operate) yourself 24) Person undergoing treatment with consciousness disorder, dementia, etc. or those who need treatment 25) People with sensitive skin or those with allergies to gels 26) Those who put bolts in the body 27) Epilepsy person 28) Others who judged that the examination responsible doctor or shared medical doctor is ineligible as a target 29) Those who had prescription changes for diabetes medication within 3 months |
|||
| Target sample size | 18 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Department of Orthopedics, Kurume University School of Medicine | ||||||
| Division name | Division of Rehabilitation | ||||||
| Zip code | 830-0011 | ||||||
| Address | 67 asahi-machi, Kurume Fukuoka | ||||||
| TEL | 0942-31-7568 | ||||||
| matsuse_hiroh@kurume-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Department of Orthopedics, Kurume University School of Medicine | ||||||
| Division name | Division of Rehabilitation | ||||||
| Zip code | 830-0011 | ||||||
| Address | 67 asahi-machi, Kurume Fukuoka | ||||||
| TEL | 0942-31-7568 | ||||||
| Homepage URL | |||||||
| bekki_masafumi@med.kurume-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kurume University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Orthopedics, Kurume University School of Medicine |
| Address | 67 asahi-machi, Kurume Fukuoka |
| Tel | 0942-31-7568 |
| bekki_masafumi@med.kurume-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 15 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033548 |